Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 256580, 9 pages
http://dx.doi.org/10.1155/2015/256580
Research Article

Candida Bloodstream Infections in Italy: Changing Epidemiology during 16 Years of Surveillance

Hygiene Section, Department of Biomedical Science and Human Oncology, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy

Received 4 December 2014; Revised 18 April 2015; Accepted 20 April 2015

Academic Editor: Handan Wand

Copyright © 2015 Giuseppina Caggiano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Diekema, S. Arbefeville, L. Boyken, J. Kroeger, and M. Pfaller, “The changing epidemiology of healthcare-associated candidemia over three decades,” Diagnostic Microbiology and Infectious Disease, vol. 73, no. 1, pp. 45–48, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Ben-Ami, M. Weinberger, R. Orni-Wasserlauff et al., “Time to blood culture positivity as a marker for catheter-related candidemia,” Journal of Clinical Microbiology, vol. 46, no. 7, pp. 2222–2226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Wisplinghoff, T. Bischoff, and S. M. Tallent, “Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study,” Clinical Infectious Diseases, vol. 9, pp. 309–317, 2004. View at Google Scholar
  4. J. Ericsson, E. Chryssanthou, L. Klingspor et al., “Candidaemia in Sweden: a nationwide prospective observational survey,” Clinical Microbiology and Infection, vol. 19, no. 4, pp. E218–E221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Pfaller and D. J. Diekema, “Epidemiology of invasive candidiasis: a persistent public health problem,” Clinical Microbiology Reviews, vol. 20, no. 1, pp. 133–163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Pemán, E. Cantón, G. Quindós et al., “Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 5, pp. 1181–1187, 2012. View at Publisher · View at Google Scholar
  7. J. Kriengkauykiat, J. I. Ito, and S. S. Dadwal, “Epidemiology and treatment approaches in management of invasive fungal infections,” Clinical Epidemiology, vol. 3, no. 1, pp. 175–191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. F. G. de Rosa, E. M. Trecarichi, C. Montrucchio et al., “Mortality in patients with early- or late-onset candidaemia,” Journal of Antimicrobial Chemotherapy, vol. 68, no. 4, pp. 927–935, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Pfaller, D. Andes, M. C. Arendrup et al., “Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria,” Diagnostic Microbiology and Infectious Disease, vol. 70, no. 3, pp. 330–343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Pfaller and D. J. Diekema, “Microdilution methods, 2010 to 2012 and laboratory standards institute broth testing of Candida spp. by use of clinical progress in antifungal susceptibility,” Journal of Clinical Microbiology, vol. 50, no. 9, pp. 2846–2856, 2012. View at Google Scholar
  11. M. A. Pfaller, D. J. Diekema, R. N. Jones et al., “International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program,” Journal of Clinical Microbiology, vol. 39, no. 9, pp. 3254–3259, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Diekema, S. A. Messer, L. B. Boyken et al., “In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods,” Journal of Clinical Microbiology, vol. 47, no. 10, pp. 3170–3177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Clinical and Laboratory Standards Institute, “Reference method for broth dilution antifungal susceptibility testing of yeasts—third informational supplement,” Tech. Rep. M27-A3, CLSI, Wayne, Pa, USA, 2008. View at Google Scholar
  14. M. C. Arendrup, B. Bruun, J. J. Christensen et al., “National surveillance of fungemia in Denmark (2004 to 2009),” Journal of Clinical Microbiology, vol. 49, no. 1, pp. 325–334, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Rennert, H. S. Rennert, S. Pitlik, R. Finkelstein, and R. Kitzes-Cohen, “Epidemiology of candidemia—a nationwide survey in Israel,” Infection, vol. 28, no. 1, pp. 26–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Li, W. Zhang, S. Zheng, Z. Ma, P. Zhang, and Z. Liu, “Surveillance study of candidemia in cancer patients in North China,” Medical Mycology, vol. 51, no. 4, pp. 378–384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Faria-Ramos, J. Neves-Maia, E. Ricardo et al., “Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 33, no. 12, pp. 2241–2247, 2014. View at Publisher · View at Google Scholar
  18. A. L. Motta, G. M. D. de Almeida, J. N. de Almeida Jr., M. N. Burattini, and F. Rossi, “Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex,” Brazilian Journal of Infectious Diseases, vol. 14, no. 5, pp. 441–448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. T. Montagna, G. Lovero, O. De Giglio et al., “Invasive fungal infections in Neonatal Intensive Care Units of Southern Italy: a multicentre regional active surveillance (Aurora Project),” Journal of Preventive Medicine and Hygiene, vol. 51, no. 3, pp. 125–130, 2010. View at Google Scholar · View at Scopus
  20. M. T. Montagna, O. de Giglio, C. Napoli et al., “Invasive fungal infections in patients with hematologic malignancies (Aurora Project): lights and shadows during 18-months surveillance,” International Journal of Molecular Sciences, vol. 13, no. 1, pp. 774–787, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. T. Montagna, G. Caggiano, G. Lovero et al., “Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project),” Infection, vol. 41, no. 3, pp. 645–653, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Wisplinghoff, J. Ebbers, L. Geurtz et al., “Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities,” International Journal of Antimicrobial Agents, vol. 43, no. 1, pp. 78–81, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Spiliopoulou, S. Vamvakopoulou, C. Bartzavali, G. Dimitracopoulos, E. D. Anastassiou, and M. Christofidou, “Eleven-year retrospective survey of candidaemia in a university hospital in southwestern Greece,” Clinical Microbiology and Infection, vol. 16, no. 9, pp. 1378–1381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Guinea, Ó. Zaragoza, P. Escribano et al., “Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 3, pp. 1529–1537, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Matsumoto, L. Boyken, S. Tendolkar et al., “Candidemia surveillance in Iowa: emergence of echinocandin resistance,” Diagnostic Microbiology and Infectious Disease, vol. 79, no. 2, pp. 205–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Barchiesi, G. Caggiano, L. F. Di Francesco, M. T. Montagna, S. Barbuti, and G. Scalise, “Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit,” Diagnostic Microbiology & Infectious Disease, vol. 49, no. 4, pp. 269–271, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. J. C. O. Sardi, L. Scorzoni, T. Bernardi, A. M. Fusco-Almeida, and M. J. S. Mendes Giannini, “Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options,” Journal of Medical Microbiology, vol. 62, supplement 1, pp. 10–24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Pfaller, M. Castanheira, S. A. Messer, G. J. Moet, and R. N. Jones, “Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009),” Diagnostic Microbiology and Infectious Disease, vol. 68, no. 3, pp. 278–283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Pfaller, D. R. Andes, D. J. Diekema et al., “Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004–2008,” PLoS ONE, vol. 9, no. 7, Article ID e101510, 2014. View at Publisher · View at Google Scholar
  30. B. D. Alexander, M. D. Johnson, C. D. Pfeiffer et al., “Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations,” Clinical Infectious Diseases, vol. 56, no. 12, pp. 1724–1732, 2013. View at Publisher · View at Google Scholar